Regulation & law · 10/12/2021
Wyeth Pharmaceuticals, LLC Proposes mRNA Bulk Drug Substance Production in Foreign-Trade Zone 27-Boston, Massachusetts
Wyeth Pharmaceuticals, LLC has submitted a notification to the U.S. Foreign-Trade Zone Board to establish a production facility for mRNA bulk drug substance in Foreign-Trade Zone 27-Boston, Massachusetts, located in Andover, Massachusetts.
Original source language: Federal Register — All DocumentsOpen original release →